IFI35 and renal cell adenocarcinoma: Table 1 summarized the clinicopathologic features of the RCC patients. Notably, increased expression of IFI35 was associated with poor overall (p < 0.05) or disease-specific 5-year patients’ survival (p < 0.05) (Figure 1C,D).